The Use of international GerdQ questionnaire - GERDq

Study identifier:NIS-GRU-XXX-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Observational non-interventional study on the use of international GerdQ questionnaire for the diagnosis of gastroesophageal reflux disease in the Russian practice

Medical condition

Gastroesophageal Reflux Disease

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

150

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Feb 2012

Primary Completion Date: 01 Jun 2012

Study Completion Date: 01 Jun 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

Location

Research site

Moscow, Russian Federation

Arms	Assigned Interventions
1	-

Documents available

CSR-NIS-GRU-XXX-2011-1
Download
CSR-NIS-GRU-XXX-2011-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information

001-800-236-9933

information.center@astrazeneca.com

Investigators

Principal Investigator

Alexey Stepanov

AstraZeneca